Literature DB >> 3588058

Decreased phosphatidyl choline content in bronchoalveolar lavage fluids of children with bronchopulmonary dysplasia: a preliminary investigation.

A Clement, J Masliah, B Housset, J Just, J Garcia, A Grimfeld, G Tournier.   

Abstract

Bronchoalveolar lavage (BAL) was performed on 12 infants who had recovered from neonatal acute respiratory failure and on 12 patients with bronchopulmonary dysplasia (BPD) in order to evaluate the concentration of phosphatidyl choline (PC) in BAL fluid. These two groups were similar at birth (mean birth weight: 1,980 and 1,750 g, respectively; mean gestational age: 33.4 and 32.1 weeks respectively). Mechanical ventilation based on oxygen requirement lasted longer in the group with BPD. BAL was performed at the end of the first year of life (at 8.5 and 10.3 months, respectively) and the results were compared to control values (from infants of the same age without neonatal disease). Whereas the protein concentration in BAL fluid was similar in the two groups, a dramatic decrease of the BAL PC was found in BPD: The mean values of BAL-PC over protein ratio were 0.9 in the group without pulmonary sequelae and 0.3 in the group with BPD. These preliminary results suggest an impairment of the pulmonary surfactant metabolism in this chronic lung disease following neonatal acute respiratory failure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3588058     DOI: 10.1002/ppul.1950030205

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

Review 1.  Bronchopulmonary dysplasia: a new look at management.

Authors:  D P Southall; M P Samuels
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Quantitative lipidomic analysis of mouse lung during postnatal development by electrospray ionization tandem mass spectrometry.

Authors:  Srikanth Karnati; Vannuruswamy Garikapati; Gerhard Liebisch; Paul P Van Veldhoven; Bernhard Spengler; Gerd Schmitz; Eveline Baumgart-Vogt
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.